Change - Announcement of Cessation::RESIGNATION OF LEAD INDEPENDENT DIRECTOR

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
17-Oct-2022 20:01:54
Status
New
Announcement Sub Title
RESIGNATION OF LEAD INDEPENDENT DIRECTOR
Announcement Reference
SG221017OTHR81AH
Submitted By (Co./ Ind. Name)
Song Tang Yih
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Resignation of Mr Leong Yow Seng as the Lead Independent Director of Biolidics Limited (the "Company")

This announcement has been prepared by the Company and has been reviewed by the Company's sponsor, United Overseas Bank Limited (the "Sponsor"), for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lim Hoon Khiat, Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898.

Additional Details

Name Of Person
Leong Yow Seng
Age
50
Is effective date of cessation known?
Yes
If yes, please provide the date
31/10/2022
Detailed Reason (s) for cessation
Mr Leong Yow Seng has decided to resign as the Lead Independent Director of the Company to focus on his other existing work commitments.

Based on its enquiries, the Sponsor is satisfied that, save as disclosed in this announcement, there is no other material reason for the cessation of Mr Leong Yow Seng as the Lead Independent Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
20/11/2018
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
7
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Lead ID, Chairman of Remuneration Committee ("RC"), Member of Audit Committee ("AC") and Nominating Committee ("NC") of the Company.
Role and responsibilities
Responsibilities as the Lead Independent Director of the Company, Chairman of the RC and Member of the AC and the NC.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Directorships
Past (for the last 5 years)
Nil
Present
Nil